Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-27 Purchase | 2024-09-12 3:23 pm | Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO | 5,101 | $3.37 | $17,190 | 259,701 (Direct) | View |
| 2024-06-21 Purchase | 2024-07-02 11:47 am | Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO | 1,600 | $2.8 | $4,480 | 254,600 (Direct) | View |
| 2023-12-27 Purchase | 2024-01-03 11:48 am | Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO | 2,700 | $4.76 | $12,852 | 253,000 (Direct) | View |
| 2023-12-14 Purchase | 2023-12-18 5:30 pm | Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO | 900 | $4.92 | $4,428 | 250,300 (Direct) | View |
| 2023-12-06 Purchase | 2023-12-11 2:04 pm | Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO | 1,500 | $5.07 | $7,605 | 249,400 (Direct) | View |
| 2023-09-11 Purchase | 2023-09-18 10:04 am | Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO | 1,500 | $5.43 | $8,145 | 247,900 (Direct) | View |
| 2023-08-28 Purchase | 2023-09-05 07:43 am | Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO | 3,400 | $4.69 | $15,946 | 246,400 (Direct) | View |
| 2023-08-18 Purchase | 2023-08-28 10:13 am | Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO | 8,000 | $4.32 | $34,560 | 243,000 (Direct) | View |
| 2022-12-12 Sale | 2023-01-05 2:26 pm | Biostage Inc. | BSTG | He Junli Director | 135 | $6.83 | $922 | 235,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-11 Option Award | 2024-01-12 8:09 pm | N/A 2034-01-11 | Harvard Apparatus Regenerative Technology Inc. | HRGN | He Junli CEO | 220,640 | $0 | 220,640 (Direct) | View |
| 2023-04-10 Option Award(A) | 2023-07-10 3:47 pm | N/A 2033-04-10 | Biostage Inc. | BSTG | He Junli CEO | 267,616 | $0 | 267,616 (Direct) | View |
| 2023-04-10 Option Award | 2023-04-12 11:24 am | N/A 2033-04-10 | Biostage Inc. | BSTG | He Junli CEO | 1,220,640 | $0 | 1,220,640 (Direct) | View |
| 2022-06-29 Option Award | 2022-07-01 5:48 pm | N/A 2032-06-29 | Biostage Inc. | BSTG | He Junli Director | 11,257 | $0 | 11,257 (Direct) | View |
| 2022-05-18 Option Award | 2022-05-20 7:02 pm | 2022-05-18 2032-05-18 | Biostage Inc. | BSTG | He Junli Director | 6,813 | $0 | 6,813 (Direct) | View |
| 2021-09-05 Option Award | 2021-11-10 8:38 pm | N/A 2031-09-05 | Biostage Inc. | BSTG | He Junli Director | 19,622 | $0 | 30,517 (Direct) | View |
Ownership | 2021-11-10 8:36 pm | N/A N/A | Biostage Inc. | BSTG | He Junli Director | 0 | $0 | 235,135 (Direct) | View |